Detalles de la búsqueda
1.
In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.
Chemotherapy
; 53(3): 194-201, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17356270
2.
Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.
J Clin Pharmacol
; 45(11): 1294-304, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16239363
3.
Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration.
J Clin Pharmacol
; 45(2): 168-76, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15647409
4.
Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Clin Ther
; 27(5): 599-608, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15978309
5.
In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
Clin Ther
; 27(9): 1444-51, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16291417
Resultados
1 -
5
de 5
1
Próxima >
>>